Özet:

Purpose: Acute cholecystitis causes percutaneous cholecystostomy is often used as an alternative treatment method for patients with high risk of surgery. However, the need for interval cholecystectomy in these patients should still be discussed. In our study, we aimed at studying the results of percutaneous cholestostomy we applied in patients with high surgical risk of acute cholecystitis. Method and method: 952 patients diagnosed with acute cholecystitis between September 2013 and June 2016 were included in the study of 27 patients we applied percutaneous cholecystostomy. The demographic data of patients, comorbid conditions, time of application of percutaneous cholestostomy, hospitalization periods and complications associated with percutaneous cholestostomy and re-application cases were recorded. The average age for working is 73±12. 4 (December: 49–97) years of age 16 women and 11 men were included. Saptanan complicated diseases were recorded as ischemic heart disease(n=6), diabetes mellitus (n=5), chronic obstructive lung disease (n=6) and others (n=10). The average time of application of percutaneous cholesystostomy was determined to be 2.2 ± 1.4 (1-3) days. The average duration of stay in the hospital was 9.6 ± 2.1 (7-14) days, and the catheter of patients was withdrawn after 1 month. The average tracking time was 19.6±8.6 (December: 10-38) month. Only 6 patients (22.2%) returned to the hospital and 4 of these patients were subjected to cholesystectomy. The result: Percutaneous cholestostomy in patients with high surgical risk of acute cholecystitis is a safe and sufficient initiative, despite the ongoing discussions. The need for intraval cholecystectomy should only be considered in a small group of patients with recurring acute cholecystitis attacks. In the wider hsta series to support our results, there is a tend to work with longer tracking periods.

Anahtar Kelimeler: